InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
Source: SeekingAlpha
2025-02-13 02:33:43 ET
More on InMed Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
InMed Pharmaceuticals GAAP EPS of -$3.64, revenue of $1.11M
InMed Pharmaceuticals Inc.
NASDAQ: INM
INM Trading
-6.01% G/L:
$0.7746 Last:
13,168 Volume:
$0.79 Open:
INM Latest News
March 09, 2026 07:30:00 am
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
March 06, 2026 05:04:00 pm
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
February 11, 2026 05:23:00 pm
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
INM Stock Data
$2,888,312
2,780,350
4.07%
5
N/A
Pharmaceuticals
Healthcare
CA
Vancouver
